Big Pharma: Suppression of a Cure for Caner

According to the Center for Disease Control and Prevention (CDC), cancer kills an estimated 576,691 patients a year--making it the second leading cause of death in the U.S (cdc.gov). In 2014, there are an estimated 1.6 million new cases of Cancer (cancer.org). Cancer, however, is not just frightening business, it’s big business. The price of treating cancer has reached $100,000 per patient, per year. One “kit” of chemotherapy drugs can cost upwards of $5000. Large pharmaceutical companies and the medical industry as a whole are profiting massively from the treatment of cancer patients. While medical professionals continue to search for a cure, the large players in the medical and pharmaceutical industry seem to have alternative motives. Over the last century, cancer treatment and our understanding of cancer has remained relatively the same. The medical field continues to only accept the three traditional (ineffective and dangerous) treatments of cancer: surgery, radiation, and chemotherapy. Two of those three treatments are in fact carcinogenic. Any alternative treatments of cancer are completely ignored, and do not undergo proper tests by the FDA. The treatment’s creator is at best labeled a “quack”, and are often subject to libel, and unjust prosecution that result in the disallowance of their treatment and the termination of their facilities. Big Pharma (the nickname given to large pharmaceutical companies) is suppressing the cure for cancer because cancer makes these corporations money. The often natural and inexpensive methods of curing cancer proposed are a threat to the capital generated by the treatment of the disease. If a simple and natural cure was discovered, the whole industry would crumble.
The companies that make up the pharmaceutical industry are among the largest in the world. The pharmaceutical market is worth $300 billion dollars, with an expected rise to $400 billion next year with Pfizer, Johnson and Johnson, and Bayer leading the way (World...